Leslie Donato, Ph.D., DABCC, Co-Director of the Cardiovascular Laboratory Medicine and Co-Director of the Hospital Clinical Laboratory and Point-of-Care Testing at Mayo Clinic in Rochester, recently authored an article in Clinical...
Jeff Meeusen, Ph.D., a clinical chemist and Co-Director of Cardiovascular Laboratory Medicine at Mayo Clinic in Rochester, recently authored an article in Clinical Laboratory News that discusses patient fasting in lipid testing. While...
Sleep Disorder Testing - Mayo Clinic Laboratories
Determining orexin-A/ hypocretin-1 levels through CSF testing provides a sensitive and specific result to guide appropriate treatment for patients.
Pathways Case Studies - Insights
The Pathways program provides anatomic and clinical pathology cases that include a history, potential answers, rationale, and relevant references directly from Mayo Clinic fellows, physicians, scientists, and allied health staff.
Enhancing Personalized Medicine with Cardiovascular Genomics - Insights
PACE / State of FLIn this month’s “Virtual Lecture” Linnea Baudhuin, Ph.D., professor of laboratory medicine and pathology in the division of laboratory genetics and genomics, discusses inherited cardiovascular conditions and identifies...
International contact information - Insights
Learn how to connect with Mayo Clinic Laboratories to discuss international testing.
Transfusion Decisions - Insights
PACE / State of FLIn this month’s “Virtual Lecture” Justin Kreuter, M.D., discusses how coagulation works and how to make appropriate transfusion decisions.
Autoimmune Neurology Testing - Insights
Autoimmune neurology is a rapidly evolving subspecialty driven by the discovery that the immune system can target virtually any structure within the
Next-generation sequencing - Insights
Learn more about the advantages offered by Mayo Clinic Laboratories’ next-generation sequencing panel for plasma cell neoplasms.
Advanced Crohn's monitoring test launched by Mayo Clinic - Insights
Mayo Clinic Laboratories introduces an advancement in the management of Crohn's disease with the release of a new laboratory test that measures Risankizumab levels in patients. This test will advance the therapeutic monitoring of Crohn's...